Biora Therapeutics Inc Revenue Growth Rates (BIOR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Biora Therapeutics Inc   (NASDAQ: BIOR)
 

BIOR's Revenue Growth by Quarter and Year

Biora Therapeutics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BIOR Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September -
2nd Quarter June 3.21
1st Quarter March 0.03
FY 3.24

BIORs Annual Revenue
Biora Therapeutics Inc 's Revenue in the fiscal year 2023 $ 0.00 millions
Biora Therapeutics Inc 's Revenue in the fiscal year 2022 $ 0.31 millions
Biora Therapeutics Inc 's Revenue in the fiscal year 2021 $ 1.25 millions
Biora Therapeutics Inc 's Revenue in the fiscal year 2020 $ 74.31 millions
Biora Therapeutics Inc 's Revenue in the fiscal year 2017 $ 0.65 millions




BIOR Revenue second quarter 2024 Y/Y Growth Comment
Biora Therapeutics Inc in the second quarter 2024 achieved Revenue of $ 3.21 millions compare to recorded in same quarter a year ago.

Among companies who have reported second quarter 2024 results in the Major Pharmaceutical Preparations industry only one Company has achieved higher year on year Revenue results in the second quarter 2024. While Biora Therapeutics Inc ' s Revenue no change of 0% ranks overall at the positon no. 11 in the second quarter 2024.


BIOR Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - - - -78.26 %
3rd Quarter September - - - -99.55 %
2nd Quarter June - - -97.73 % -96.92 %
1st Quarter March - - -55.56 % -99.31 %
FY   - 855.56 % -89.16 % -

Financial Statements
Biora Therapeutics Inc 's second quarter 2024 Revenue $ 3.21 millions BIOR's Income Statement
Biora Therapeutics Inc 's second quarter 2023 Revenue $ 0.00 millions Quarterly BIOR's Income Statement


BIOR Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - -40.74 % - -9.09 %
3rd Quarter September - - - -75 %
2nd Quarter June 10616.64 % - -87.5 % 144.44 %
1st Quarter March -90.63 % - -20 % -60.87 %
FY (Year on Year)   - 855.56 % -89.16 % -


Back to BIOR Growth rate Comparisons >> Back to BIOR Growth rate Comparisons >>


Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #4
Overall #11

Revenue Y/Y Growth Statistics
High Average Low
745.83 % 25.98 % -100 %
(Sep 30 2011)   (Mar 31 2020)
Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #4
Overall #11
Revenue Y/Y Growth Statistics
High Average Low
745.83 % 25.98 % -100 %
(Sep 30 2011)   (Mar 31 2020)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Biora Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
745.83 % 25.98 % -100 %
(Sep 30 2011)  


BIOR's II. Quarter Q/Q Revenue Comment
Biora Therapeutics Inc achieved in the II. Quarter 2024 above company average sequential Revenue doubling of 10616.64%, to $ 3.21 millions, from $0.03 millions in the first quarter.
BIOR is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry only one company achieved higher sequential Revenue growth. While Biora Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 11.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #4
Overall #11
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #4
Overall #11
Revenue Q/Q Growth Statistics
High Average Low
745.83 % 25.98 % -100 %
(Sep 30 2011)  


BIOR's II. Quarter Q/Q Revenue Comment
Biora Therapeutics Inc achieved in the II. Quarter 2024 above company average sequential Revenue doubling of 10616.64%, to $ 3.21 millions, from $0.03 millions in the first quarter.
BIOR is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry only one company achieved higher sequential Revenue growth. While Biora Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 11.


Biora Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
Biora Therapeutics Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2024, compare to Revenue of $ 0 millions a year ago.

Biora Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
Biora Therapeutics Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2024, compare to Revenue of $ 0 millions a year ago.

Biora Therapeutics Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BIOR's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Biora Therapeutics Inc Revenue Growth Rates (BIOR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.